Henri Beaufour | |
|---|---|
| Born | Henri Pierre Albert Marie Beaufour January 1965 (age 60) |
| Nationality | French |
| Alma mater | Georgetown University |
| Board member of | Ipsen |
| Parent | Albert Beaufour |
| Relatives | Anne Beaufour (sister) |
Henri Beaufour (born January 6, 1965 [1] ) is a French businessman and billionaire. He is a descendant of Henri Beaufour, founder of the Beaufour laboratories, forerunner of the French biopharmaceutical company Ipsen. [2]
Born in January 1965, in Neuilly-sur-Seine, Henri Beaufour is the son of Albert Beaufour, who died in 2000, and the grandson of Dr. Henri Beaufour, founder of the Ipsen group. [2]
He holds a bachelor's of arts from Georgetown University (Washington, D.C.).
When Albert Beaufour died in 2000, the 76% of the capital held by the family was divided between the three brothers and sisters. One of the daughters, Véronique Beaufour, sold her share, representing 6% of the capital. Anne and her brother Henri Beaufour thus control 57% of the Ipsen group, and both sit on the Board of Directors of Ipsen and Mayroy, the Ipsen controlling holding company. Their share in Ipsen is still 52% in 2020. [3]
In 2018, his fortune is estimated at Euro 3 billion. [4] [5]